JP2024546803A5 - - Google Patents
Info
- Publication number
- JP2024546803A5 JP2024546803A5 JP2024534714A JP2024534714A JP2024546803A5 JP 2024546803 A5 JP2024546803 A5 JP 2024546803A5 JP 2024534714 A JP2024534714 A JP 2024534714A JP 2024534714 A JP2024534714 A JP 2024534714A JP 2024546803 A5 JP2024546803 A5 JP 2024546803A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- weeks
- once
- mol
- conjugate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163289371P | 2021-12-14 | 2021-12-14 | |
| US63/289,371 | 2021-12-14 | ||
| US202263323126P | 2022-03-24 | 2022-03-24 | |
| US63/323,126 | 2022-03-24 | ||
| US202263325923P | 2022-03-31 | 2022-03-31 | |
| US63/325,923 | 2022-03-31 | ||
| US202263343505P | 2022-05-18 | 2022-05-18 | |
| US63/343,505 | 2022-05-18 | ||
| US202263374632P | 2022-09-06 | 2022-09-06 | |
| US63/374,632 | 2022-09-06 | ||
| PCT/US2022/081541 WO2023114833A1 (en) | 2021-12-14 | 2022-12-14 | Dosing regimens for selective treg stimulator rur20kd-il-2 and related compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024546803A JP2024546803A (ja) | 2024-12-26 |
| JP2024546803A5 true JP2024546803A5 (https=) | 2025-12-23 |
Family
ID=85157281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024534714A Pending JP2024546803A (ja) | 2021-12-14 | 2022-12-14 | 選択的Ｔｒｅｇ刺激剤ＲＵＲ２０ｋＤ－ＩＬ－２及び関連組成物の投与計画 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250049934A1 (https=) |
| EP (1) | EP4447995A1 (https=) |
| JP (1) | JP2024546803A (https=) |
| KR (1) | KR20240123817A (https=) |
| AU (1) | AU2022414070A1 (https=) |
| CA (1) | CA3239501A1 (https=) |
| IL (1) | IL313567A (https=) |
| MX (1) | MX2024007345A (https=) |
| WO (1) | WO2023114833A1 (https=) |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4401756A (en) | 1981-04-14 | 1983-08-30 | Immunex Corporation | Process for preparing human interleukin 2 |
| US4569790A (en) | 1984-03-28 | 1986-02-11 | Cetus Corporation | Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions |
| US5116943A (en) | 1985-01-18 | 1992-05-26 | Cetus Corporation | Oxidation-resistant muteins of Il-2 and other protein |
| US5153310A (en) | 1989-02-28 | 1992-10-06 | Du Pont Merck Pharmaceutical Company | Il-2 analogs containing n-linked glycosylation sites |
| US5635597A (en) | 1994-05-27 | 1997-06-03 | Affymax Technologies, N.V. | Peptides that bind IL-2 receptors |
| US6168785B1 (en) | 1998-07-16 | 2001-01-02 | Institut Pasteur | Biological applications of new peptides of IL-2 and derivatives and use as therapeutic agents |
| FR2826365B1 (fr) | 2001-06-20 | 2003-09-26 | Oreal | Compositions cosmetiques photoprotectrices contenant des derives amides, sulfonamides ou carbamates aromatiques d'acrylonitrile et nouveaux derives amides, sulfonamides ou carbamates d'acrylonitrile |
| EP2644206B1 (en) | 2003-05-23 | 2019-04-03 | Nektar Therapeutics | PEG derivatives containing two PEG chains |
| US7569215B2 (en) | 2003-07-18 | 2009-08-04 | Massachusetts Institute Of Technology | Mutant interleukin-2 (IL-2) polypeptides |
| US7567215B1 (en) | 2007-10-23 | 2009-07-28 | The United States Of America As Represented By The Secretary Of The Navy | Portable and inflatable antenna device |
| WO2012065086A1 (en) | 2010-11-12 | 2012-05-18 | Nektar Therapeutics | Conjugates of an il-2 moiety and a polymer |
| BR112020021564A2 (pt) | 2018-05-21 | 2021-03-02 | Nektar Therapeutics | estimulador de treg seletivo rur20kd-il-2 e composições relacionadas |
| WO2019241549A1 (en) | 2018-06-15 | 2019-12-19 | A2 Biotherapeutics, Inc. | Foxp3-expressing car-t regulatory cells |
| CA3119439A1 (en) | 2018-11-09 | 2020-05-14 | Regenex LLC | Treatment method for graft-versus-host disease |
| CA3122843A1 (en) | 2018-12-12 | 2020-06-18 | The Brigham And Women's Hospital, Inc. | Compositions and methods for immunosuppression |
| EP4150060A4 (en) | 2020-05-13 | 2024-06-19 | Rapa Therapeutics, LLC | TREATMENT OR PREVENTION OF PRO-INFLAMMATORY DISEASES OR CONDITIONS USING INDUCED REGULATORY T CELLS (IT) |
-
2022
- 2022-12-14 EP EP22851299.2A patent/EP4447995A1/en active Pending
- 2022-12-14 MX MX2024007345A patent/MX2024007345A/es unknown
- 2022-12-14 WO PCT/US2022/081541 patent/WO2023114833A1/en not_active Ceased
- 2022-12-14 US US18/718,703 patent/US20250049934A1/en active Pending
- 2022-12-14 AU AU2022414070A patent/AU2022414070A1/en active Pending
- 2022-12-14 CA CA3239501A patent/CA3239501A1/en active Pending
- 2022-12-14 JP JP2024534714A patent/JP2024546803A/ja active Pending
- 2022-12-14 KR KR1020247022370A patent/KR20240123817A/ko active Pending
- 2022-12-14 IL IL313567A patent/IL313567A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7286595B2 (ja) | 抗体製剤 | |
| EP3988083B1 (en) | Long-acting growth hormone dosage forms | |
| RU2010114018A (ru) | Применение пептид тимозина бета 4 индивидуально или в сочетании с цекропином а в качестве терапевтического средства | |
| CZ292775B6 (cs) | Fyziologicky aktivní konjugát polyethylenglykol-interferon alfa, způsob jeho přípravy a farmaceutický prostředek, který ho obsahuje | |
| HUP0002877A2 (hu) | Stabil inzulinkészítmények és eljárás előállításukra | |
| JP2020105227A (ja) | インスリン含有医薬組成物 | |
| JP4234439B2 (ja) | Ｉｌ−１２発現調節剤 | |
| US20220211799A1 (en) | Compositions and methods for modulating complement activity | |
| RU2010113989A (ru) | Применение пептида в качестве терапевтического средства | |
| WO2021152184A1 (en) | Compositions comprising at least an amylin receptor agonist and a glp-1 receptor agonist | |
| EP4547218A1 (en) | Tirzepatide compositions and use | |
| AU2022246002B2 (en) | Incretin analog-containing compositions and uses thereof | |
| JP2023549455A5 (https=) | ||
| CN116568309B (zh) | 一种用于预防或治疗慢性乙型肝炎的药物组合制剂及其用途以及组合制剂试剂盒 | |
| MXPA04005712A (es) | Composiciones que comprenden epotilonas y su uso para el tratamiento de sindrome carcinoide. | |
| JP2024546803A5 (https=) | ||
| JP2024086815A (ja) | 薬物動態及び／又は安全性に優れるテリパラチド含有液状医薬組成物 | |
| US20180236080A1 (en) | Fast-acting insulin composition comprising a citric acid salt | |
| AU2005277404A1 (en) | Methods of healing wounds by administering human IL-18 | |
| EP0603383B1 (en) | Compositions and methods for treating autoimmune diseases | |
| JP2021533201A5 (https=) | ||
| US20240009148A1 (en) | Cystamine Formulations and Uses Thereof | |
| HK40082838A (en) | Compositions comprising at least an amylin receptor agonist and a glp-1 receptor agonist | |
| HK40055016A (en) | Treatment of warts | |
| KR20230035600A (ko) | Ghrh 유사체의 저-용량 약제학적 조성물 및 이들의 용도 |